StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for AXIM Biotechnologies

AXIM Biotechnologies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More AXIM Biotechnologies figures

See a number that looks wrong?